Cite
HARVARD Citation
Van Eldik, L. et al. (2021). First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. Clinical pharmacology in drug development. 10 (2), pp. 131-143. [Online].